Insulin human (Pfizer)

N/A

Report date: 2022/05/16 17:57:42

Base Information

Drug NameInsulin human (Pfizer)
Drug Alias NameExubera (吸入型胰岛素)人源胰岛素（辉瑞）ExuberaHMR 4006
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2006/01/24
Country/TerritoryCanadaUnited StatesSweden +[17] 
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesNektar TherapeuticsPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer LtdPfizer Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A